PT95789A - Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis - Google Patents

Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis

Info

Publication number
PT95789A
PT95789A PT95789A PT9578990A PT95789A PT 95789 A PT95789 A PT 95789A PT 95789 A PT95789 A PT 95789A PT 9578990 A PT9578990 A PT 9578990A PT 95789 A PT95789 A PT 95789A
Authority
PT
Portugal
Prior art keywords
insulating
bordetella pertussis
antigenic factors
purifying
purifying antigenic
Prior art date
Application number
PT95789A
Other languages
English (en)
Other versions
PT95789B (pt
Inventor
Carine Capiau
Pierre Desmons
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of PT95789A publication Critical patent/PT95789A/pt
Publication of PT95789B publication Critical patent/PT95789B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/20Partition-, reverse-phase or hydrophobic interaction chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
PT95789A 1989-11-06 1990-11-05 Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis PT95789B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43199989A 1989-11-06 1989-11-06

Publications (2)

Publication Number Publication Date
PT95789A true PT95789A (pt) 1991-09-13
PT95789B PT95789B (pt) 1997-12-31

Family

ID=23714322

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95789A PT95789B (pt) 1989-11-06 1990-11-05 Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis

Country Status (16)

Country Link
EP (1) EP0427462B1 (pt)
JP (1) JP3148895B2 (pt)
KR (1) KR0161281B1 (pt)
AT (1) ATE134194T1 (pt)
AU (1) AU635083B2 (pt)
CA (1) CA2029201C (pt)
CY (1) CY1934A (pt)
DE (1) DE69025375T2 (pt)
DK (1) DK0427462T3 (pt)
ES (1) ES2084668T3 (pt)
GR (1) GR3019725T3 (pt)
HK (1) HK1004555A1 (pt)
IE (1) IE71687B1 (pt)
NZ (1) NZ235960A (pt)
PT (1) PT95789B (pt)
ZA (1) ZA908801B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0835663T3 (da) 1992-05-23 2010-02-01 Glaxosmithkline Biolog Sa Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
ES2136290T3 (es) * 1994-04-28 1999-11-16 Takeda Chemical Industries Ltd Metodo para separar componentes protectores de bordetella pertussis.
DE19512346C1 (de) * 1995-04-01 1996-06-13 Behringwerke Ag Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
WO2013113729A1 (en) 2012-02-01 2013-08-08 Glaxosmithkline Biologicals S.A. Fermentation process
KR102236498B1 (ko) 2013-03-08 2021-04-06 얀센 백신스 앤드 프리벤션 비.브이. 무세포 백일해 백신
CN112513248A (zh) * 2018-03-20 2021-03-16 圣诺菲·帕斯图尔公司 培育博德特氏菌属菌种的方法
KR102362777B1 (ko) * 2018-03-27 2022-02-15 주식회사 녹십자 친화성 크로마토그래피 공정을 포함하는 백일해균 유래 단백질 수득 방법
WO2019189471A1 (ja) * 2018-03-27 2019-10-03 日本精工株式会社 ステアリング装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500639A (en) 1981-10-15 1985-02-19 Teijin Limited Culturing Bordetella in media containing etherified cyclodextrin
JPS59175439A (ja) 1983-03-23 1984-10-04 Teijin Ltd 繊維状赤血球凝集素の製法
CA1213234A (en) 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
JPS6098988A (ja) 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Lpf−haの精製法
US4563303A (en) 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
GB8601279D0 (en) 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
FR2596413B1 (fr) 1986-03-27 1988-06-10 Merieux Inst Nouveaux milieux de culture de bacteries appartenant au genre bordetella, contenant des derives etherifies de polymeres de d-glucose, et leur application

Also Published As

Publication number Publication date
ATE134194T1 (de) 1996-02-15
PT95789B (pt) 1997-12-31
KR910009283A (ko) 1991-06-28
AU635083B2 (en) 1993-03-11
DE69025375T2 (de) 1996-08-01
IE71687B1 (en) 1997-02-26
DE69025375D1 (de) 1996-03-28
AU6584690A (en) 1991-05-09
DK0427462T3 (da) 1996-03-11
JPH03169893A (ja) 1991-07-23
EP0427462B1 (en) 1996-02-14
GR3019725T3 (en) 1996-07-31
ES2084668T3 (es) 1996-05-16
IE903969A1 (en) 1991-05-08
JP3148895B2 (ja) 2001-03-26
HK1004555A1 (en) 1998-11-27
NZ235960A (en) 1993-11-25
ZA908801B (en) 1991-11-27
CA2029201C (en) 2002-07-30
CA2029201A1 (en) 1991-05-07
EP0427462A1 (en) 1991-05-15
KR0161281B1 (ko) 1998-12-01
CY1934A (en) 1990-11-01

Similar Documents

Publication Publication Date Title
DE69636147D1 (de) Verfahren zur herstellung von phosphorothioat-oligomeren
NO1997010I1 (no) Bordetella pertussis P69 antigen
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DK0686195T3 (da) Fremgangsmåde og system til forhöjet produktion af kommercielt vigtige exoproteiner i grampositive bakterier
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
FI101380B (fi) Menetelmä 69 000 daltonin antigeeniproteiinin puhdistamiseksi Bordetel la pertussis -bakteerista
DE3781541T2 (de) Modifiziertes pertussistoxin.
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
FI952144A (fi) Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle
ES2088431T3 (es) Preparacion biologica y su utilizacion.
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
DK0719560T3 (da) Acellulær antibordetellavaccine
DE69534635D1 (de) Verfahren zur produktion von verstärkt antigen wirkenden heliobacter sp. und vakzine die diesen enthalten
DE3869885D1 (de) Verfahren zur herstellung des gereinigten naphthalin-2,6-dicarbonsaeure-bis (2-hydroxyethyl)-esters.
AU603794B2 (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
ATE159758T1 (de) Azelluläre impfstoffe
AU603794C (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910404

FG3A Patent granted, date of granting

Effective date: 19970901

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120903